LianBio Announces Groundbreaking Results from Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex Blepharitis.
Ocular Disease: Novel Results Announced By This Biotech Company
Ocular Disease: Novel Results Announced By…
Ocular Disease: Novel Results Announced By This Biotech Company
LianBio Announces Groundbreaking Results from Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex Blepharitis.